Phobic Disorders
25
1
1
17
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
8.0%
2 terminated out of 25 trials
89.5%
+3.0% vs benchmark
12%
3 trials in Phase 3/4
18%
3 of 17 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 17 completed trials
Clinical Trials (25)
Reward Processing and Exposure Therapy for Social Anxiety Disorder
Validation of Turkish Versions Child- and Parent-Rated Scales of Food Allergy Anxiety
A Safety and Efficacy Study of JNJ-42165279 in Participants With Social Anxiety Disorder
ACT-smart: Smartphone-supplemented iCBT for Social Phobia and/or Panic Disorder
Smartphone-Based Exposure Treatment for Dental Anxiety
Explanatory Clinical Trial of a Novel Parent Intervention for Childhood Anxiety (SPACE)
Neurophysiological Correlates of Exposition Therapy in Spider Phobia
Facilitation of Fear Extinction With Yohimbine Hydrochloride in Phobic Participants
Effectiveness & Cost-effectiveness of Internet-delivered Interventions for Depression and Anxiety Disorders in IAPT
RCT of Cognitive Therapy, Paroxetine, Combined CT and Paroxetine and Placebo
The Role of Treatment Expectation in Exposure Training With Spider Fearful Participants
Treatment of Social Phobia
Effect of Including Synera® in Discussions on Dialysis Access Conversion in Patients With Needle Phobias
In Vivo Versus Augmented Reality Exposure for Small Animal Phobia
Validity of a Self-administered Questionnaire to Screen Phobia of Falling in the Elderly
Virtual Reality and Concept of Control in the Treatment of Acrophobia
Noradrenergic Manipulation and Virtual Reality Exposure Therapy in Phobic Participants
Threat-Avoidance Learning in Anxiety Patients
Use of an Antibiotic as an Enhancer for the Treatment of Social Phobia
A Research Study of How Teens With and Without an Anxiety Disorder Make Decisions